These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38158912)

  • 1. [Current status and prospects of using the prokinetic acotiamide in gastroenterology: A review].
    Maev IV; Andreev DN; Zaborovsky AV; Lobanova EG
    Ter Arkh; 2023 Oct; 95(8):716-721. PubMed ID: 38158912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-World, Non-Interventional, Observational Study to Evaluate Effectiveness and Tolerability of Acotiamide Hydrochloride Hydrate in Treatment of Functional Dyspepsia.
    Porika SK; Veligandla KC; Muni SK; Acharya S; Mehta SC; Sharma AD
    Adv Ther; 2018 Nov; 35(11):1884-1893. PubMed ID: 30350248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence-based clinical practice guidelines for functional dyspepsia 2021.
    Miwa H; Nagahara A; Asakawa A; Arai M; Oshima T; Kasugai K; Kamada K; Suzuki H; Tanaka F; Tominaga K; Futagami S; Hojo M; Mihara H; Higuchi K; Kusano M; Arisawa T; Kato M; Joh T; Mochida S; Enomoto N; Shimosegawa T; Koike K
    J Gastroenterol; 2022 Feb; 57(2):47-61. PubMed ID: 35061057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy of gastroesophageal reflux disease and functional dyspepsia overlaps with symptoms after usual-dose proton pump inhibitor: Acotiamide plus usual-dose proton pump inhibitor versus double-dose proton pump inhibitor.
    Takeuchi T; Takahashi Y; Kawaguchi S; Ota K; Harada S; Kojima Y; Sakamoto H; Kuramoto T; Kojima K; Sanomura M; Hoshimoto M; Higashino T; Itabashi T; Takada K; Sakaguchi M; Tominaga K; Kusano M; Higuchi K
    J Gastroenterol Hepatol; 2018 Mar; 33(3):623-630. PubMed ID: 28865098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acotiamide, a new orally active acetylcholinesterase inhibitor, stimulates gastrointestinal motor activity in conscious dogs.
    Nagahama K; Matsunaga Y; Kawachi M; Ito K; Tanaka T; Hori Y; Oka H; Takei M
    Neurogastroenterol Motil; 2012 Jun; 24(6):566-74, e256. PubMed ID: 22429221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acotiamide Hydrochloride, a Therapeutic Agent for Functional Dyspepsia, Enhances Acetylcholine-induced Contraction via Inhibition of Acetylcholinesterase Activity in Circular Muscle Strips of Guinea Pig Stomach.
    Ito K; Kawachi M; Matsunaga Y; Hori Y; Ozaki T; Nagahama K; Hirayama M; Kawabata Y; Shiraishi Y; Takei M; Tanaka T
    Drug Res (Stuttg); 2016 Apr; 66(4):196-202. PubMed ID: 26418413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acotiamide: first global approval.
    Nowlan ML; Scott LJ
    Drugs; 2013 Aug; 73(12):1377-83. PubMed ID: 23881665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acotiamide (Z-338) as a possible candidate for the treatment of functional dyspepsia.
    Suzuki H; Hibi T
    Neurogastroenterol Motil; 2010 Jun; 22(6):595-9. PubMed ID: 20553562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging treatments in neurogastroenterology: Acotiamade, a novel treatment option for functional dyspepsia.
    Matsushita M; Masaoka T; Suzuki H
    Neurogastroenterol Motil; 2016 May; 28(5):631-8. PubMed ID: 26730749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging drugs for functional dyspepsia.
    Zala AV; Walker MM; Talley NJ
    Expert Opin Emerg Drugs; 2015 Jun; 20(2):221-33. PubMed ID: 25645940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of acotiamide on functional dyspepsia patients with heartburn who failed proton pump inhibitor treatment in Japanese patients: A randomized, double-blind, placebo-controlled crossover study.
    Funaki Y; Ogasawara N; Kawamura Y; Yoshimine T; Tamura Y; Izawa S; Ebi M; Sasaki M; Kasugai K
    Neurogastroenterol Motil; 2020 Feb; 32(2):e13749. PubMed ID: 31612597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiologically-Based Pharmacokinetic and Pharmacodynamic Modeling for the Inhibition of Acetylcholinesterase by Acotiamide, A Novel Gastroprokinetic Agent for the Treatment of Functional Dyspepsia, in Rat Stomach.
    Yoshii K; Iikura M; Hirayama M; Toda R; Kawabata Y
    Pharm Res; 2016 Feb; 33(2):292-300. PubMed ID: 26350104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of acotiamide on esophageal motor function and gastroesophageal reflux in healthy volunteers.
    Ishimura N; Mori M; Mikami H; Shimura S; Uno G; Aimi M; Oshima N; Ishihara S; Kinoshita Y
    BMC Gastroenterol; 2015 Sep; 15():117. PubMed ID: 26362795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of advanced systemic sclerosis with severe GERD successfully treated with acotiamide.
    Kato R; Nakajima K; Takahashi T; Miyazaki Y; Makino T; Kurokawa Y; Yamasaki M; Takiguchi S; Mori M; Doki Y
    Surg Case Rep; 2016 Dec; 2(1):36. PubMed ID: 27072944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acotiamide hydrochloride (Z-338), a new selective acetylcholinesterase inhibitor, enhances gastric motility without prolonging QT interval in dogs: comparison with cisapride, itopride, and mosapride.
    Matsunaga Y; Tanaka T; Yoshinaga K; Ueki S; Hori Y; Eta R; Kawabata Y; Yoshii K; Yoshida K; Matsumura T; Furuta S; Takei M; Tack J; Itoh Z
    J Pharmacol Exp Ther; 2011 Mar; 336(3):791-800. PubMed ID: 21123674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of acotiamide on epigastric pain syndrome and postprandial distress syndrome in patients with functional dyspepsia.
    Shinozaki S; Osawa H; Sakamoto H; Hayashi Y; Kawarai Lefor A; Yamamoto H
    J Med Invest; 2016; 63(3-4):230-5. PubMed ID: 27644564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Randomized, Double-Blind, Pilot Study of the Effect of Famotidine on Acotiamide Treatment for Functional Dyspepsia.
    Hojo M; Nagahara A; Asaoka D; Takeda T; Izumi K; Matsumoto K; Ueyama H; Shimada Y; Matsumoto K; Nojiri S; Watanabe S
    Digestion; 2017; 96(1):5-12. PubMed ID: 28605740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of acotiamide in combination with esomeprazole for functional dyspepsia refractory to proton-pump inhibitor monotherapy.
    Mayanagi S; Kishino M; Kitagawa Y; Sunamura M
    Tohoku J Exp Med; 2014 Nov; 234(3):237-40. PubMed ID: 25382232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of functional dyspepsia: state of the art and emerging therapies.
    Yamawaki H; Futagami S; Wakabayashi M; Sakasegawa N; Agawa S; Higuchi K; Kodaka Y; Iwakiri K
    Ther Adv Chronic Dis; 2018 Jan; 9(1):23-32. PubMed ID: 29344328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Approaches to Diagnosis and Treatment of Functional Dyspepsia.
    Tomita T; Oshima T; Miwa H
    Curr Gastroenterol Rep; 2018 Oct; 20(12):55. PubMed ID: 30338390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.